- Home
- RAND vs RENB Comparison
RAND vs RENB Comparison
Compare RAND & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAND
- RENB
- Stock Information
- Founded
- RAND 1969
- RENB 2011
- Country
- RAND United States
- RENB United States
- Employees
- RAND N/A
- RENB N/A
- Industry
- RAND Finance: Consumer Services
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- RAND Finance
- RENB Health Care
- Exchange
- RAND Nasdaq
- RENB Nasdaq
- Market Cap
- RAND 54.4M
- RENB 57.7M
- IPO Year
- RAND N/A
- RENB N/A
- Fundamental
- Price
- RAND $16.13
- RENB $0.24
- Analyst Decision
- RAND
- RENB
- Analyst Count
- RAND 0
- RENB 0
- Target Price
- RAND N/A
- RENB N/A
- AVG Volume (30 Days)
- RAND 5.0K
- RENB 840.7K
- Earning Date
- RAND 08-04-2025
- RENB 10-09-2025
- Dividend Yield
- RAND 10.35%
- RENB N/A
- EPS Growth
- RAND N/A
- RENB N/A
- EPS
- RAND N/A
- RENB N/A
- Revenue
- RAND $7,966,118.00
- RENB N/A
- Revenue This Year
- RAND N/A
- RENB N/A
- Revenue Next Year
- RAND N/A
- RENB N/A
- P/E Ratio
- RAND N/A
- RENB N/A
- Revenue Growth
- RAND 1.16
- RENB N/A
- 52 Week Low
- RAND $13.82
- RENB $0.22
- 52 Week High
- RAND $31.89
- RENB $2.10
- Technical
- Relative Strength Index (RSI)
- RAND 46.94
- RENB 43.90
- Support Level
- RAND $15.17
- RENB $0.22
- Resistance Level
- RAND $16.20
- RENB $0.27
- Average True Range (ATR)
- RAND 0.91
- RENB 0.02
- MACD
- RAND 0.06
- RENB 0.00
- Stochastic Oscillator
- RAND 71.52
- RENB 35.71
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.